Amneal Pharmaceuticals Inc
0.00 (0.00%)


Draw Mode:

Volume 0
Bid Price
Ask Price
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Amneal Pharmaceuticals Inc AMRX NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.39 04:00:02
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 1.3126 - 4.60
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 1.39 USD

Amneal Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 210.59M 151.50M 102.89M $ 2.21B $ -248.44M -0.86 318.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -3.88M 2.70%

more financials information »

Amneal Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No AMRX Message Board. Create One! See More Posts on AMRX Message Board See More Message Board Posts

Historical AMRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.361.531.31261.441,066,7330.032.21%
1 Month2.262.261.31261.691,180,176-0.87-38.5%
3 Months1.982.741.31262.071,138,111-0.59-29.8%
6 Months2.032.741.31262.171,114,126-0.64-31.53%
1 Year4.0254.601.31262.621,013,977-2.64-65.47%
3 Years3.937.4451.31264.181,164,542-2.54-64.63%
5 Years17.0024.481.31266.331,308,160-15.61-91.82%

Amneal Pharmaceuticals Description

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.